Judgment of the Court (Fourth Chamber), 19 July 2012

Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents

Reference for a preliminary ruling from the Court of Appeal (England and Wales) (Civil Division)

Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining a supplementary protection certificate — Medicinal product having obtained a valid marketing authorisation — First authorisation — Product successively authorised as a veterinary medicinal product and a human medicinal product

Case C‑130/11


Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex
Judgment (OJ)
14/09/2012 Neurim Pharmaceuticals (1991)
View pdf documents
Judgment
ECLI:EU:C:2012:489
19/07/2012 Neurim Pharmaceuticals (1991)
EUR-Lex text EUR-Lex bilingual text
Judgment (Summary)
ECLI:EU:C:2012:489
19/07/2012 Neurim Pharmaceuticals (1991)
Opinion
ECLI:EU:C:2012:268
03/05/2012 Neurim Pharmaceuticals (1991)
EUR-Lex text EUR-Lex bilingual text
Application (OJ)
27/05/2011 Neurim Pharmaceuticals (1991)
View pdf documents
Top of the page Legal analysis of the decision or of the case

Reports of Cases

published in the electronic Reports of Cases (Court Reports - general)

Subject-matter

Information not available

Systematic classification scheme

1.
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 null
      4.11.14.03 null
        4.11.14.03.00
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 null
      4.11.14.03 null
        4.11.14.03.02
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 null
      4.11.14.03 null
        4.11.14.03.01


Citations of case-law or legislation

References in grounds of judgment

  • Directive 2001/83 -A08P3 : paragraphs 1, 11, 16, 32, 33, 35, 36
  • Regulation 469/2009 : paragraph 22
  • Regulation 469/2009 -A01 : paragraph 4
  • Regulation 469/2009 -A02 : paragraphs 5, 20, 24
  • Regulation 469/2009 -A03 : paragraphs 1, 6, 16, 18 - 21, 27
  • Regulation 469/2009 -A03LD : paragraphs 16, 26
  • Regulation 469/2009 -A04 : paragraphs 7, 16, 18, 24, 27
  • Regulation 469/2009 -A05 : paragraph 24
  • Regulation 469/2009 -A07P1 : paragraph 8
  • Regulation 469/2009 -A13P1 : paragraphs 1, 9, 16, 28 - 31
  • Regulation 469/2009 -A23 : paragraph 10
  • Regulation 469/2009 -A3LB : paragraphs 29, 30
  • Regulation 469/2009 -C1 : paragraph 3
  • Regulation 469/2009 -C10 : paragraph 3
  • Regulation 469/2009 -C4 : paragraph 3
  • Regulation 469/2009 -C5 : paragraph 3
  • Regulation 469/2009 -C6 : paragraph 3
  • Regulation 469/2009 -C7 : paragraph 3
  • Regulation 469/2009 -C8 : paragraph 3
  • Regulation 469/2009 -C9 : paragraph 3
  • Court of Justice - Judgment C -127/00 : paragraph 29
  • Court of Justice - Judgment C -195/09 : paragraph 20
  • Court of Justice - Judgment C -322/10 : paragraphs 22 - 24
  • Court of Justice - Judgment C -422/10 : paragraphs 22, 23
  • Court of Justice - Order C -630/10 : paragraph 24

Operative part

  • Interprets : Regulation 469/2009 -A03
  • Interprets : Regulation 469/2009 -A04
  • Interprets : Regulation 469/2009 -A13P1
  • Interprets : Directive 2001/83 -A08P3

Opinion

  • TFEU, Article 267 : point 1
  • Directive 65/65 : points 26, 35
  • Directive 65/65 -A04 : point 73
  • Directive 81/851 : points 26, 35
  • Regulation 1768/92 : points 1, 14, 51, 62
  • Regulation 1768/92 -A01 : points 2, 22, 24
  • Regulation 1768/92 -A03 : points 1, 3, 21, 24, 29 - 38
  • Regulation 1768/92 -A03LA : point 1
  • Regulation 1768/92 -A03LB : points 1, 25, 27
  • Regulation 1768/92 -A03LC : point 1
  • Regulation 1768/92 -A03LD : points 1, 14, 18 - 64, 73
  • Regulation 1768/92 -A04 : points 3, 14, 55
  • Regulation 1768/92 -A05 : point 3
  • Regulation 1768/92 -A07 : point 4
  • Regulation 1768/92 -A07P1 : point 43
  • Regulation 1768/92 -A13 : points 5, 19, 40, 56, 65
  • Regulation 1768/92 -A13P1 : points 14, 44, 73
  • Regulation 1768/92 -A19 : point 19
  • Regulation 1768/92 -C4 : point 40
  • Regulation 1768/92 -C8 : point 40
  • Regulation 1610/96 -A03P2 : point 61
  • Directive 2001/82 : point 35
  • Directive 2001/83 : points 26, 35
  • Directive 2001/83 -A08P3 : points 14, 69
  • Regulation 469/2009 : point 1
  • Regulation 469/2009 -A01LB : point 22
  • Regulation 469/2009 -A03LA : point 1
  • Regulation 469/2009 -A03LB : point 1
  • Commission - COM Document (Draft Legislation) - 51990PC0101 : point 50
  • Court of Justice - Judgment C -181/95 : points 36, 54
  • Court of Justice - Judgment C -392/97 : point 32
  • Court of Justice - Judgment C -127/00 : point 66
  • Court of Justice - Judgment C -31/03 : point 68
  • Court of Justice - Judgment C -482/07 : points 36, 43, 61
  • Court of Justice - Opinion C -195/09 : point 19
  • Court of Justice - Judgment C -195/09 : point 63
  • Court of Justice - Judgment C -427/09 : point 63
  • Court of Justice - Opinion C -322/10 : point 22
  • Court of Justice - Judgment C -125/10 : point 28
  • Court of Justice - Judgment C -322/10 : points 1, 36, 39, 54, 60
  • Court of Justice - Judgment C -422/10 : points 1, 36, 39, 54, 60
  • Court of Justice - Order C -518/10 : point 32
  • Court of Justice - Order C -630/10 : points 32, 36
  • Court of Justice - Order C -6/11 : point 32


Dates

Date of the lodging of the application initiating proceedings

  • 16/03/2011

Date of the Opinion

  • 03/05/2012

Date of the hearing

Information not available

Date of delivery

19/07/2012


References

Publication in the Official Journal

Application: OJ C 179 from 18.06.2011, p.7

Judgment: OJ C 295 from 29.09.2012, p.9

Name of the parties

Neurim Pharmaceuticals (1991)

Notes on Academic Writings

  1. Roset, Sebastien: Autorisation de mise sur le marché des médicaments, Europe 2012 Octobre Comm. nº 10 p.28 (FR)
  2. Inman, Paul ; Spink, Simon: Neurim: Episode IV - a new hope, Journal of Intellectual Property Law and Practice 2012 p.696-698 (EN)
  3. Forni, Federico: La nuova indicazione di un vecchio principio attivo conquista il certificato protettivo complementare, Diritto comunitario e degli scambi internazionali 2012 p.399-428 (IT)
  4. Kupecz, A.F.: Intellectuele eigendom & Reclamerecht 2013 p.72-73 (NL)
  5. Schell, Jürgen: Neurim - ein neuer Erzeugnisbegriff bei ergänzenden Schutzzertifikaten?, Gewerblicher Rechtsschutz und Urheberrecht INT 2013 p.509-513 (DE)



Procedural Analysis Information

Source of the question referred for a preliminary ruling

Court of Appeal (England & Wales) (Civil Division) - United Kingdom

Subject-matter

  • Approximation of laws
  • Intellectual, industrial and commercial property
  • - Patents

Procedure and result

  • Reference for a preliminary ruling

Formation of the Court

quatrième chambre (Cour)

Judge-Rapporteur

Bonichot

Advocate General

Trstenjak

Language(s) of the Case

  • English

Language(s) of the Opinion

  • German